LumiraDx obtains CE mark for two Fast Lab Solutions molecular tests
The two multiplex tests are developed using LumiraDx's qSTAR single-step nucleic acid extraction and amplification technology.
Covid-19
Latest in
Covid-19
SeaStar reports data from immunomodulator device study
The pilot study assessed the safety and efficacy of the SCD in Covid-19 ICU patients with multiple organ failure.
Rising healthcare costs threaten hospital wellbeing
The Covid-19 pandemic has not just been a threat to public wellbeing, but to the continuation of the healthcare field…
By
The impact of Covid-19 on the in vitro diagnostics market
The global in vitro diagnostics market is projected to decline at a compound annual growth rate (CAGR) of 4% from…
By
Proof Diagnostics seeks EUA for Covid-19 molecular diagnostic test
The Proof Lab Test System is expected to become the first POC system to use CRISPR-based nucleic acid detection.
Australian TGA approves Seegene’s Allplex RV Master Assay
Medical specialists can use the syndromic test to identify the virus making a patient sick from one sample.
KSL Diagnostics introduces new antibody test for Covid-19
The blood test measures antibodies that are specific to Covid-19, which develop in response to vaccination or infection.
US FDA grants EUA for Helix COVID-19 self-collection kit
The Helix COVID-19 Self-Collection Kit will be available to consumers from participating pharmacies and urgent care centres.